U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
ALBUTREPENONACOG ALFA
A57KX1VL5P
US Approved Rx (2016)
First approved in 2016
General
Record Details
Names
9
Classification
3
Identifiers
11
Subunits
1
Disulfide Links
28
Glycosylation
4
Relationships
1
Active Moiety
1
Characteristic Attributes
2
ALBUTREPENONACOG ALFA
A57KX1VL5P
US Approved Rx (2016)
First approved in 2016
General
Approval Year
2016
495
Record Details
Substance Class
Protein
Protein Sub Type
Sequence Type
COMPLETE
Record UNII
A57KX1VL5P
Record Status
Validated (UNII)
Record Version
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
9
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
ALBUTREPENONACOG ALFA
Official Name
English
IDELVION
Brand Name
English
Albutrepenonacog alfa [WHO-DD]
Common Name
English
CSL-654
Code
English
ALBUTREPENONACOG ALFA [MI]
Common Name
English
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated/Approved
ORPHAN DRUG
Designated/Approved
Treatment of patients with congenital factor IX deficiency (hemophilia B).
FDA ORPHAN DRUG
366712
GINETIC DISEASES, X-LINKED
EMA EMPR
DISEASES
CONGENITAL, HEREDITARY, AND NEONATAL DISESES AND ABNORMALITIES
GENETIC DISEASES, INBORN
GINETIC DISEASES, X-LINKED
HEMOPHILIA B
EMA ASSESSMENT REPORTS
INDELVION (AUTHORIZED: HEMOPHILIA B)
Positive
EU ORPHAN DRUG
Positive
Treatment of haemophilia B
EU-Orphan Drug
EU/3/09/723
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
11
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
DAILYMED
A57KX1VL5P
PRIMARY
NCI_THESAURUS
C171813
PRIMARY
FDA UNII
A57KX1VL5P
PRIMARY
EVMPD
SUB174139
PRIMARY
SMS_ID
100000160835
PRIMARY
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Subunits
1
Subunit 0
>SUBUNIT_0
Disulfide Links
28
Show
5
20
100
All
entries
From
To
From
To
1_18
1_23
1_51
1_62
1_56
1_71
1_73
1_82
1_88
1_99
Showing 1 to 5 of 28 entries
Previous
1
2
3
4
5
6
Next
Glycosylation
4
Show
5
20
100
All
entries
Glycosylation Link Type
Site
Glycosylation Link Type
Site
N
1_157
N
1_167
O
1_53
O
1_61
Showing 1 to 4 of 4 entries
Previous
1
Next
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
6U90Y1795T
COAGULATION FACTOR IX HUMAN
TARGET->ENZYME REPLACEMENT
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
A57KX1VL5P
ALBUTREPENONACOG ALFA
ACTIVE MOIETY
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Molecular Formula
CHEMICAL
ESTIMATED
C5065H7856N1367O1558S66
MOL_WEIGHT:NUMBER(CALCULATED)
CHEMICAL
ESTIMATED 115000 Da (average)
Showing 1 to 2 of 2 entries
Previous
1
Next
